IMUNON
LIVE

Serial Number

97036154

Owner

IMUNON, INC.

Attorney

Monica Riva Talley

Filing Date

Sep 20, 2021

Add to watchlist:

No watchlists yet
View on USPTO

IMUNON Trademark

Serial Number: 97036154

IMUNON is a trademark filed by IMUNON, INC. on September 20, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

IMUNON, INC.

997 LENOX DRIVE
LAWRENCEVILLE, NJ 08648

Entity Type: 03

Celsion Corporation (21 trademarks)

Lawrenceville, NJ 08648

Entity Type: 03

Trademark Details

Filing Date

September 20, 2021

Registration Date

Not Registered

Published for Opposition

May 16, 2023

Goods & Services

Active chemical ingredients for use in the manufacture of pharmaceuticals; chemical, biological, and biochemical preparations for scientific purposes or general industrial manufacturing

Development of platform technology, namely, cancer immunotherapy, infectious disease, and gene therapy platforms for manufacturing therapeutics; Biological and biotechnology research; research and development in the pharmaceutical and biotechnology fields; scientific research and development with regard to the manufacture of pharmaceutical preparations; chemical and biological analysis; bioinformatics analysis, namely, DNA analysis services for scientific research purposes; Development of pharmaceutical preparations for treating cancer; scientific research services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological research in the fields of genetics, immunotherapy, vaccination, and oncology

Pharmaceutical preparations, namely, immunotherapies for the treatment of cancer and infectious diseases; biological preparations for the treatment of cancer and infectious diseases; vaccines; pharmaceutical preparations for the prevention and treatment of cancer; Biological preparations for the prevention and treatment of cancer; pharmaceutical and biological preparations for the treatment of immune system related diseases and disorders; therapeutic agents for promotion of cancer immunity, namely, therapeutic pharmaceuticals and vaccines for the treatment and prevention of cancer

Filing History

ITU OFFICE ACTION ISSUED FOR EXTENSION REQUEST
Jun 4, 2026 INCE
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 4, 2026 AITU
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 1, 2026 ASGN
SOU TEAS EXTENSION RECEIVED
Jan 12, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 11, 2025 EXRA
SOU EXTENSION 4 GRANTED
Jul 11, 2025 EX4G
SOU EXTENSION 4 FILED
Jul 11, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Jul 11, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 3 GRANTED
Jan 9, 2025 EX3G
SOU EXTENSION 3 FILED
Jan 9, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 9, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 9, 2024 EXRA
SOU EXTENSION 2 GRANTED
Jul 9, 2024 EX2G
SOU EXTENSION 2 FILED
Jul 9, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 9, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 12, 2024 EXRA
SOU EXTENSION 1 GRANTED
Jan 10, 2024 EX1G
SOU EXTENSION 1 FILED
Jan 10, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 10, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 11, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 16, 2023 NPUB
PUBLISHED FOR OPPOSITION
May 16, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 26, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 10, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 5, 2023 XAEC
ASSIGNED TO LIE
Apr 5, 2023 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 5, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 5, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 5, 2023 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 11, 2023 GNFN
FINAL REFUSAL E-MAILED
Jan 11, 2023 GNFR
FINAL REFUSAL WRITTEN
Jan 11, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 29, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 28, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 28, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 1, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jul 1, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jul 1, 2022 CNRT
ASSIGNED TO EXAMINER
Jun 22, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 24, 2021 NWOS
NEW APPLICATION ENTERED
Sep 23, 2021 NWAP